Qualifying Therapeutic Discovery Project Grants for the State of North Dakota
The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.
The project descriptions below were extracted from the applicant certification forms as submitted.
| Applicant Name | Project Name | Grants Awarded for 2009 | Grants Awarded for 2010 |
|---|---|---|---|
| Aldevron LLC | Egc Superantigens for Treatment of Stage IIIB NSCLC with Pleural Effusion | $ 52,015.00 | $ 192,464.24 |
| Altravax Inc | A Therapapeutic Vaccine for Treatment of Chronic Hepatitis B Infection | $ 244,479.24 | |
| NovaDigm Therapeutics, Inc | Vaccine against Staphylococcus aureus and Candida | $ 244,479.24 |
References/Related Topics
Page Last Reviewed or Updated: 2012-10-12
